You may rely too heavily on the information provided by another physician, which is (un)popularly known as “anchoring bias.”
March 2017
Oncofertility is the specialty dealing with the clinical care of patients who will lose their fertility due to cancer treatment.
While providing information on the cancer and treatment gets a little easier with time, empathizing and accepting the emotions that patients and their families express does not.
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
3
Ixazomib-Containing Combinations Signal Potential for More PI-Based Regimens in R/R Multiple Myeloma
4
Dr Braunstein on the FDA Approval of Subcutaneous Daratumumab With VRd For Newly Diagnosed Multiple Myeloma
5